Le Lézard
Classified in: Health, Business
Subject: LIC

Ivy Rehab Network Expands through Partnership with Excel Physical Therapy

WHITE PLAINS, N.Y., Sept. 15, 2021 /PRNewswire/ -- Ivy Rehab Network, ("Ivy") a national leader in outpatient musculoskeletal rehabilitative services, is proud to announce its largest partnership to date with Excel Physical Therapy. This partnership expands Ivy's market-leading footprint to 73 locations in the greater Philadelphia market, and over 300 locations nationwide. 

"Joining the Ivy Rehab Network will further empower our team to continue Excel's mission to help people return to the activities they love, and to deliver high-quality care to our community," said Kristin Mullen, CEO of Excel Physical Therapy. "We are looking forward to growing together with Ivy throughout southeast Pennsylvania in order to provide additional convenient clinic options for our patients." 

Excel Physical Therapy, comprised of 36 clinics in the greater Philadelphia area, is known for its customer service-oriented approach and dedication to clinical excellence. Since opening in 1990, Excel has provided effective manual therapy treatment through hands-on, individualized care by licensed physical therapists. Throughout the last three decades, this long-standing practice has leveraged its wealth of experience to serve thousands of patients in Pennsylvania to become the well-established market leader they are today.

"We are excited to join together for this strategic partnership to leverage our collective strengths," said Troy Bage, Ivy's COO. "It's an honor to partner with highly-esteemed industry veterans with local, proven experience and expertise. Together, we will provide best-in-class services for our communities."

Michael Rucker, CEO of Ivy, further added "The team at Excel is comprised of passionate and dedicated physical therapists and business leaders, who embrace a strong culture of service. The ideals and values of Ivy and Excel are very well aligned, and we couldn't be more excited to join forces and grow together across the Delaware Valley region."

About Ivy Rehab 
Founded in 2003, Ivy Rehab is a rapidly growing network of best-in-class outpatient physical, occupational, speech, and ABA therapy clinics located throughout the United States. The Ivy Rehab Network consists of multiple brands, all dedicated to providing exceptional care and personalized treatment to get patients feeling better, faster. With the support of leading middle-market private equity firm Waud Capital Partners, Ivy Rehab will continue its strategic growth via the ongoing investment in new partners who embrace our mission, vision, and values as well as a culture of being "All About the People." 

Contact Information: 
Ivy Rehab Network 
Jeremy VanDevender 

SOURCE Ivy Rehab Network

These press releases may also interest you

at 07:05
Taysha Gene Therapies, Inc. , a patient-centric, pivotal-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system (CNS) in both rare and large...

at 07:05
Kiromic BioPharma, Inc. ("Kiromic" or the "Company"), a clinical-stage fully integrated biotherapeutics company using its proprietary DIAMOND® artificial intelligence (AI) platform to discover and develop cell and gene therapies with a therapeutic...

at 07:05
Concert Pharmaceuticals, Inc. today announced that it has completed patient enrollment in THRIVE-AA1, the first Phase 3 clinical trial to evaluate the efficacy and safety of CTP?543, an oral Janus kinase (JAK) inhibitor, in adult patients with...

at 07:05
OncoNano Medicine, Inc. today announced that the Cancer Prevention and Research Institute of Texas (CPRIT) will convert $18.4 million in grant award funding into an equity investment in OncoNano. Proceeds of the financing will be used to support...

at 07:05
Castle Biosciences, Inc. , a company applying innovative diagnostics to inform disease management decisions and improve patient outcomes, today announced that it will release its financial results for the third quarter and nine months ended Sept. 30,...

at 07:01
RedHill Biopharma Ltd. ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced the presentation of four new analyses of Phase 3 Talicia® (omeprazole magnesium, amoxicillin and rifabutin)[1] and Movantik® (naloxegol)[2]...

News published on 15 september 2021 at 10:15 and distributed by: